• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region
Dermatology

ADVENT at Diversity in Dermatology 2024 | Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Join Drs Sarina Elmariah and Mona Shahriari as they discuss the diagnostic considerations for atopic dermatitis and prurigo nodularis and uncovered how clinical signs and itch in these diseases are impacted by type 2 inflammation.
Sarina Elmariah
Mona  Shahriari
MD, PhD
Sarina Elmariah +1 more
See post-event materials
Past event
22March2024
Location
San Antonio United States

Learning objectives

  • Identify diagnostic considerations and challenges associated with atopic dermatitis and prurigo nodularis
  • Describe how clinical signs and itch in atopic dermatitis and prurigo nodularis are impacted by type 2 inflammation

Description

This symposium will highlight the diagnostic considerations for atopic dermatitis and prurigo nodularis and uncovered how clinical signs and itch in these diseases are impacted by type 2 inflammation.

 

Agenda:

Welcome

Sarina Elmariah

The Journey to Diagnosis: Disease Burden and Diagnostic Considerations for Atopic Dermatitis and Prurigo Nodularis

Mona Shahriari, Sarina Elmariah

Type 2 inflammation: A Common Link Between Atopic Dermatitis and Prurigo Nodularis

Sarina Elmariah, Mona Shahriari

Audience Q&A

Mona Shahriari, Sarina Elmariah

Location

San Antonio United States
Tags
symposium
MAT-US-2401638 v1.0 - P Expiration Date 03/23/2024

Speakers

Dermatology
MD, PhD

Sarina Elmariah

Associate Professor and Dermatology Director at the UCSF Centre for Itch and Neurosensory Disorders at the University of California in San Francisco, California, US

Dermatology
MD

Mona Shahriari

Assistant clinical professor of dermatology at Yale University School of Medicine in New Haven, Connecticut and co-founder of Central Connecticut Dermatology in Cromwell, Connecticut, US